2016 China Protein Medicine Quality and Technology Innovation Seminar was held in Taicang, Jiangsu Province
March 12-13, 2016, co-sponsored by China Protein Drug Quality Alliance, Jiangsu Taicang City Government and Tianjin International Biomedical Research Institute, Tianjin Binhai New Area Protein Drug Quality and Industrial Technology Innovation Research Association, Taicang City Biological The “2016 China Protein Drug Quality and Technology Innovation Seminar” jointly organized by the Pharmaceutical Industry Park and Suzhou Jinmeng Biotechnology Co., Ltd. was held at the Four Points by Sheraton, Taicang Baolong. More than 300 representatives from major biopharmaceutical R&D institutions and corporate leaders, core technicians, pharmaceutical equipment and instrument manufacturing companies attended the seminar.
Shanghai Yaxin Bio-Biotechnology Co., Ltd. participated as an exhibitor and presented the company's new series of products, sequencing grade trypsin, sequencing grade carboxypeptidase B, and so on. Professor Li Suxia, the company's chief scientist, gave a speech and sharing on the problems encountered by sequencing-grade trypsin in the process of antibody and protein sequencing.
Speaker: Professor Li Suxia
Title: Scientific questions of peptide-mapping analysis of protein and antibody
Report content: Peptide mapping analysis technology, discussed the problems faced by peptide mapping analysis, and shared solutions to specific problems such as protein, antibody pretreatment, enzymatic digestion conditions, and enzyme digestion with trypsin and methylation modification.
Contact Person: Mr. zhao